Trademark: 90294501
Word
CIFI
Status
Pending
Status Code
730
Status Date
Monday, November 8, 2021
Serial Number
90294501
Mark Type
4000
Filing Date
Monday, November 2, 2020
Published for Opposition
Tuesday, May 25, 2021

Trademark Owner History
Arima Genomics Inc. - Owner At Publication

Classifications
5 Diagnostic preparations for medical purposes; diagnostic preparations for humans for medical purposes; diagnostic preparations for medical and veterinary purposes, namely, diagnostic preparations, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances in the nature of reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, namely, diagnostic reagents, enzymes and diagnostic reagents in the nature of buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, in the nature of reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits containing preparations for medical and veterinary diagnostic purposes primarily consisting of diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in the nature of nucleic acids, proteins, macromolecules and biologically active substances, in the nature of reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing
1 Reagents for scientific and research use; Enzymes for scientific and research use; Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprising enzymes for scientific and research purposes; Reagents for scientific and research use in the field of molecular biology and cell biology applications; Enzymes for scientific and research use in the field of molecular biology and cell biology applications; Reagents for scientific and research use for amplification of DNA; Reagent kits for amplification of DNA comprising at least one of enzymes, buffers, and nucleic acids for use in biotechnology fields for scientific and research purposes; Reagents for scientific and research use for use in nucleic acid sequencing for scientific and research purposes; Kits for use in nucleic acid sequencing, namely, kits for molecular biology and cell biology applications comprised of at least one of enzymes, buffers, and nucleic acids for scientific and research purposes; kits for molecular biological research, namely, sequencing kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors
44 Gene analysis and sequencing as well as DNA analysis and sequencing for medical diagnostic purposes; gene analysis and sequencing as well as DNA analysis and sequencing for use in cancer diagnosis and treatment
42 Scientific research services, namely, gene analysis and sequencing as well as DNA analysis and sequencing; scientific research services, namely, preparation of materials for gene analysis and sequencing as well as DNA analysis and sequencing

Trademark Events
Nov 10, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 8, 2021
Sou Extension 1 Granted
Nov 8, 2021
Sou Extension 1 Filed
Nov 8, 2021
Teas Extension Received
Jul 20, 2021
Noa E-Mailed - Sou Required From Applicant
May 25, 2021
Official Gazette Publication Confirmation E-Mailed
May 25, 2021
Published For Opposition
May 5, 2021
Notification Of Notice Of Publication E-Mailed
Apr 15, 2021
Approved For Pub - Principal Register
Apr 15, 2021
Examiner's Amendment Entered
Apr 15, 2021
Notification Of Examiners Amendment E-Mailed
Apr 15, 2021
Examiners Amendment E-Mailed
Apr 15, 2021
Examiners Amendment -Written
Apr 14, 2021
Teas/Email Correspondence Entered
Apr 13, 2021
Correspondence Received In Law Office
Apr 13, 2021
Teas Response To Office Action Received
Apr 5, 2021
Notification Of Non-Final Action E-Mailed
Apr 5, 2021
Non-Final Action E-Mailed
Apr 5, 2021
Non-Final Action Written
Apr 5, 2021
Assigned To Examiner
Dec 30, 2020
New Application Office Supplied Data Entered In Tram
Nov 5, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24